Combination of ipilimumab and adoptive Cell Therapy with Tumor-infiltrating lymphocytes for Patients with Metastatic Melanoma

John E. Mullinax1,2, MacLean Hall2, Sangeetha Prabhakaran3, Jeffrey Weber4, Nikhil Khushalani5, Zeynep Eroglu5, Andrew S. Brohl1,5, Joseph Markowitz2,5, Erica Royster5, Allison Richards5, Valerie Stark5, Jonathan S. Zager1,5, Linda Kelley2, Cheryl Cox2, Vernon K. Sondak5, James J. Mulé2,5, Shari Pilon-Thomas2,5 and Amod A. Sarnaik2,5 1Sarcoma Department, Moffitt Cancer Center, Tampa, FL, United States, 2Immunology Department, Moffitt Cancer Center, Tampa, FL, United States, 3Department of Surgery, University of New Mexico, Albuquerque, NM, United States, 4NYU Langone Medical Center, New York, NY, United States, 5Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, United States